ArticleTranslational animal science2023
Influence of supplemental flavomycin on growth performance, carcass characteristics, and nutrient digestibility in calf-fed Holstein steers.
Article in Translational animal science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of Adding Butyrate or Exogenous Fibrolytic Enzymes on Ruminal Epithelium, Metabolism, and Microbiota of Beef Cattle.Animals : an open access journal from MDPI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to evaluate the influence of supplemental flavomycin on cattle growth performance, carcass characteristics, diet digestibility, and ruminal fermentation characteristics of calf-fed Holstein steers. One hundred Holstein steers (123 ± 7 kg) were balanced by weight and assigned to 20 pens. Dietary treatments consisted of a steam flaked corn-based diet supplemented with (dry matter basis): 1) control, no feed additive; 2) 6.6 mg/kg flavomycin; 3) 13.2 mg/kg flavomycin, and 4) 30 mg/kg monensin (MON). There were no treatment effects (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.